The single-use assemblies market size is expected to advance at a CAGR of 15.7% during 2024–2030, to reach USD 6,901.5 million by 2030. This is ascribed to the need of end users to minimize expenses, reduce labor requirements, and save time.
The adoption of single-use assemblies has increased in the last few years in several emerging economies, including India, China, and South Korea, because of their several advantages, such as cost-savings, and the supportive regulatory policies. The key players are also strengthening their foothold in these countries, to cater better to several end users.
Due to the increasing prevalence of infectious diseases, the use of biologics is rising, which is expected to propel the market growth. Moreover, various advanced biologics are being developed for the treatment of cancer and various other diseases. In May 2022, IAVI and Moderna Inc. announced that the first participant screenings for their mRNA HIV vaccine for phase 1 trial were expected to start soon at the Center for Family Health Research in South Africa. This reflects a high-volume production of a large number of biologics for the treatment of various diseases, which is further expected to boost the market growth. The demand for single-use assemblies for the development of biologics is rising as they are easy to use and require less energy and water.
APAC is expected to witness the fastest growth over the forecast period, at a CAGR of 16.2%, attributed to the increasing investments in research and development and the advancement of the healthcare infrastructure. Facilities manufacturing single-use assemblies in the region are also being expanded, which will fuel the sale of such products.
For instance, in May 2022, Merck KGaA planned to invest around USD 110 million to significantly increase biopharma single-use assembly and custom design capabilities over six years, by expanding its existing Wuxi production site. Merck will extend its geographical presence and strengthen its supply chain in China and the rest of the Asia-Pacific region with this expansion.
Europe is also showing significant growth in the single-use assemblies market, ascribed to the rapid adoption of advanced healthcare technologies. Moreover, across the region, the key players are focusing on broadening their presence. For instance, Merck KGaA is accelerating its expansion in the European region with a EUR 25-million investment at its site in Molsheim, France, that produces COVID-19 vaccines and other life-saving therapies. Thus, the market will be driven in the coming years by the establishment of new manufacturing facilities for biologics and other kinds of drugs in the region.
The most-significant single-use assemblies market players are Sartorius AG, Thermo Fisher Scientific Inc., Merck KGaA, VWR International, LLC, Lonza Group Ltd., Compagnie de Saint-Gobain S.A., Corning Incorporated, Entegris Inc., and Adolf Kühner AG.